Insiders Updates
Scotiabank gives a Sector outperform recommendation for Tempest Therapeutics Inc (TPST)
Tempest Therapeutics Inc’s recent filing unveils that its President and CEO Brady Stephen R acquired Company’s shares for reported $73850.0
